Not sure what exactly is the Arizona reference, but it would fall under either NuGenerex Therapeutics or NuGenerex Distribution Solutions https://www.dnb.com/business-directory/compan...e46dd.html. Again see GNBT website https://www.generex.com/nugenerex-family-of-companies. So I don’t imagine any news about “Arizona” will have much (if any) perception value for GNBT until the next 10-Q/A is published by the SEC. Then the public can see how much $$$ was contributed to GNBT by all four subsidiaries. Still, any good news is good for the psyche.